1. Home
  2. DYN vs SOC Comparison

DYN vs SOC Comparison

Compare DYN & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • SOC
  • Stock Information
  • Founded
  • DYN 1984
  • SOC 2020
  • Country
  • DYN United States
  • SOC United States
  • Employees
  • DYN N/A
  • SOC N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • SOC
  • Sector
  • DYN Health Care
  • SOC
  • Exchange
  • DYN Nasdaq
  • SOC Nasdaq
  • Market Cap
  • DYN 1.9B
  • SOC 1.8B
  • IPO Year
  • DYN 2020
  • SOC N/A
  • Fundamental
  • Price
  • DYN $21.11
  • SOC $4.38
  • Analyst Decision
  • DYN Strong Buy
  • SOC Buy
  • Analyst Count
  • DYN 15
  • SOC 4
  • Target Price
  • DYN $36.53
  • SOC $17.00
  • AVG Volume (30 Days)
  • DYN 3.2M
  • SOC 8.8M
  • Earning Date
  • DYN 11-05-2025
  • SOC 11-13-2025
  • Dividend Yield
  • DYN N/A
  • SOC N/A
  • EPS Growth
  • DYN N/A
  • SOC N/A
  • EPS
  • DYN N/A
  • SOC N/A
  • Revenue
  • DYN N/A
  • SOC N/A
  • Revenue This Year
  • DYN N/A
  • SOC N/A
  • Revenue Next Year
  • DYN N/A
  • SOC $208.30
  • P/E Ratio
  • DYN N/A
  • SOC N/A
  • Revenue Growth
  • DYN N/A
  • SOC N/A
  • 52 Week Low
  • DYN $6.36
  • SOC $3.72
  • 52 Week High
  • DYN $31.32
  • SOC $35.00
  • Technical
  • Relative Strength Index (RSI)
  • DYN 58.23
  • SOC 28.46
  • Support Level
  • DYN $18.20
  • SOC $4.20
  • Resistance Level
  • DYN $21.98
  • SOC $4.86
  • Average True Range (ATR)
  • DYN 1.78
  • SOC 0.88
  • MACD
  • DYN -0.17
  • SOC 0.20
  • Stochastic Oscillator
  • DYN 57.30
  • SOC 18.24

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.

Share on Social Networks: